MENU

Fox Chase Faculty Member Recognized as Highly Cited Researcher for His Work on Immune Responses and Cancer

December 6, 2019

Sergei Grivennikov, PhD, associate professor in the Cancer Prevention and Control Program. The Highly Cited Researchers list recognizes those who have demonstrated significant and broad influence in their chosen field through the publication of multiple papers over the past decade. These highly cited papers are the publications that rank in the top 1 percent by citations for field and publication year in the Web of Science index.Sergei Grivennikov, PhD, associate professor in the Cancer Prevention and Control Program. The Highly Cited Researchers list recognizes those who have demonstrated significant and broad influence in their chosen field through the publication of multiple papers over the past decade. These highly cited papers are the publications that rank in the top 1 percent by citations for field and publication year in the Web of Science index.

PHILADELPHIA (December 6, 2019) – A Fox Chase Cancer Center researcher was named as one of 2019’s highly cited researchers by the Web of Science Group, considered to be the world’s largest publisher-neutral citation index and research intelligence platform. The organization’s annual report analyzes the influence of researchers among their peers by analyzing the metrics of citations across its worldwide, multidisciplinary database.

The body of work of Sergei Grivennikov, PhD, associate professor in the Cancer Prevention and Control Program, is included in this year’s rankings. Several of his highly cited papers were published in the journals Cell, Cancer Cell, Nature, and Immunity.

“The field of studying inflammation in cancer and the tumor microenvironment is very popular right now and so our research has been appreciated more in the years since we started publishing our work,” Grivennikov said. “I think we did some important work in the basics of understanding the role of inflammation and how it affects cancer, which would not be possible without a conducive research environment and essential collaborations.”

The Web of Science serves as a vast resource of data on scientific content curated by a thorough and independent editorial process. This not only ensures journal quality but provides comprehensive indexing to allow researchers to access the best information.

Its Highly Cited Researchers list recognizes those who have demonstrated significant and broad influence in their chosen field through the publication of multiple papers over the past decade. These highly cited papers are the publications that rank in the top 1 percent by citations for field and publication year in the Web of Science index.

Grivennikov’s research continues to focus on the immune system’s involvement in cancer through inflammatory pathways that promote tumor growth and progression, and how manipulations of the inflammation responses may aid in the development of better therapeutic and preventive approaches.

“I think it is important to emphasize that a lot of new insights come from basic scientific approaches and it is necessary that this information is made available to other researchers,” said Grivennikov. And as more researchers investigate the body’s immune and inflammation response in relation to cancer, his work could continue to serve as a foundation for inquiries into the mechanisms of immune response and tumor development.

      

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase